The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death
Open accessAbstract
Despite the adoption of “sickest first” liver transplantation, pretransplant death remains common, and many early deaths occur despite initially low Model for End-stage Liver Disease (MELD) scores. From 1997-2003, we studied 507 cirrhotic United States veterans referred for consideration of liver transplantation to identify additional predictors of early mortality. Most of the patients were male (98%) with cirrhosis caused by hepatitis C and/or alcohol (88%). Data for 296 patients referred prior to February 27, 2002 (training group), were analyzed; findings were validated in 211 patients referred subsequently (validation group). In the training group, 61 patients (21%) died within 180 days without transplantation; their median initial MELD score was 21. MELD score, persistent ascites, and low serum sodium (< 135 meq/L) were independent predictors of early mortality. In patients with a MELD score of less than 21, only low serum sodium and persistent ascites were independent predictors of mortality; for MELD scores above 21, only MELD was independently predictive. Prognostic significance of persistent ascites and low serum sodium for low MELD score patients was confirmed in the validation group. Risk varied continuously with worsening hyponatremia. Modifying MELD, by including points for persistent ascites and low serum sodium, improved prediction of early pretransplant mortality in low MELD score patients. In conclusion, persistent ascites and low serum sodium identify patients with cirrhosis with high mortality risk despite low MELD scores. Ascites, hyponatremia, and other findings indicative of hemodynamic decompensation merit further prospective study as prognostic indicators in patients awaiting liver transplantation, and should be considered in setting minimal listing criteria. Supplementary material for this article can be found on the Hepatology website (http://interscience.wiley.com/jpages/0270-9139/suppmat/index.html). (Hepatology 2004;40:802-810).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanley, J. A., & McNeil, B. J. (1983) · Radiology · doi:10.1148/radiology.148.3.6878708 · Cited by 7,016
A Model to Predict Survival in Patients With End–Stage Liver Disease
Kamath, P. S., Wiesner, R. H., Malinchoc, M., Kremers, W., Therneau, T. M., Kosberg, C. L., D'Amico, G., Dickson, R. E., & Kim, R. W. (2001) · Hepatology · doi:10.1053/jhep.2001.22172 · Cited by 4,975
Malinchoc, M., Kamath, P. S., Gordon, F. D., Peine, C. J., Rank, J., & ter Borg, P. C. J. (2000) · Hepatology · doi:10.1053/he.2000.5852 · Cited by 2,893 · cited 1×
“central office (updated through July I , 2003), and (3) searches of the Social Security Death Index (updated in August 2003).”
Model for end-stage liver disease (MELD) and allocation of donor livers
Wiesner, R., Edwards, E., Freeman, R., Harper, A., Kim, R., Kamath, P., Kremers, W., Lake, J., Howard, T., Merion, R. M., et al. (2003) · Gastroenterology · doi:10.1053/gast.2003.50016 · Cited by 2,528
Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis†
Arroyo, V, Ginès, P., Gerbes, A. L., Dudley, F. J., Gentilini, P., Laffi, G., Reynolds, T. B., Ring-Larsen, H., & Schölmerich, J. (1996) · Hepatology · doi:10.1002/hep.510230122 · Cited by 1,703
Compensated cirrhosis: Natural history and prognostic factors
Ginés, P., Quintero, E., Arroyo, V., Terés, J., Bruguera, M., Rimola, A., Caballería, J., Rodés, J., & Rozman, C. (1987) · Hepatology · doi:10.1002/hep.1840070124 · Cited by 1,106
Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites
Ginès, A., Escorsell, A., Ginès, P., Saló, J., Jiménez, W., Inglada, L., Navasa, M., Clària, J., Rimola, A., Arroyo, V., et al. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90031-7 · Cited by 891
MELD and PELD: Application of survival models to liver allocation
Wiesner, R. H., McDiarmid, S. V., Kamath, P. S., Edwards, E. B., Malinchoc, M., Kremers, W. K., Krom, R. A. F., & Kim, R. W. (2001) · Liver Transplantation · doi:10.1053/jlts.2001.25879 · Cited by 864
The new liver allocation system: Moving toward evidence-based transplantation policy
Freeman, R. B., Wiesner, R. H., Harper, A., McDiarmid, S. V., Lake, J., Edwards, E., Merion, R., Wolfe, R., Turcotte, J., & Teperman, L. (2002) · Liver Transplantation · doi:10.1053/jlts.2002.35927 · Cited by 724
Llach, J., Ginès, P., Arroyo, V., Rimola, A., Titó, L., Badalamenti, S., Jiménez, W., Gaya, J., Rivera, F., & Rodés, J. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90441-6 · Cited by 459
Cited by
D'Amico, G., Garcia-Tsao, G., & Pagliaro, L. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.10.013 · Cited by 2,687
(2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.05.004 · Cited by 1,725
The model for end-stage liver disease (MELD)
Kamath, P. S., & Kim, R. W. (2007) · Hepatology · doi:10.1002/hep.21563 · Cited by 1,674
Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List
Kim, W. R., Biggins, S. W., Kremers, W. K., Wiesner, R. H., Kamath, P. S., Benson, J. T., Edwards, E., & Therneau, T. M. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801209 · Cited by 1,486
Management of adult patients with ascites due to cirrhosis: An update†‡§
Runyon, B. A. (2009) · Hepatology · doi:10.1002/hep.22853 · Cited by 975
Biggins, S. W., Angeli, P., Garcia‐Tsao, G., Ginès, P., Ling, S. C., Nadim, M. K., Wong, F., & Kim, W. R. (2021) · Hepatology · doi:10.1002/hep.31884 · Cited by 846
Muscle Wasting Is Associated With Mortality in Patients With Cirrhosis
Montano–Loza, A. J., Meza–Junco, J., Prado, C. M. M., Lieffers, J. R., Baracos, V. E., Bain, V. G., & Sawyer, M. B. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.08.028 · Cited by 810
Evidence-Based Incorporation of Serum Sodium Concentration Into MELD
Biggins, S. W., Kim, W. R., Terrault, N. A., Saab, S., Balan, V., Schiano, T., Benson, J., Therneau, T., Kremers, W., Wiesner, R., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.02.010 · Cited by 790
Mortality after Hospitalization with Mild, Moderate, and Severe Hyponatremia
Waikar, S. S., Mount, D. B., & Curhan, G. C. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.01.027 · Cited by 724
Tandon, P., Ney, M., Irwin, I., Ma, M. M., Gramlich, L., Bain, V. G., Esfandiari, N., Baracos, V., Montano-Loza, A. J., & Myers, R. P. (2012) · Liver Transplantation · doi:10.1002/lt.23495 · Cited by 574
Salerno, F., Cammà, C., Enea, M., Rössle, M., & Wong, F. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.06.020 · Cited by 560
Sersté, T., Melot, C., Francoz, C., Durand, F., Rautou, P.-E., Valla, D., Moreau, R., & Lebrec, D. (2010) · Hepatology · doi:10.1002/hep.23775 · Cited by 530
Hyponatremia in cirrhosis: Results of a patient population survey
Angeli, P., Wong, F., Watson, H., & Ginès, P. (2006) · Hepatology · doi:10.1002/hep.21412 · Cited by 437
Müller Glial Cells in Retinal Disease
Bringmann, A., & Wiedemann, P. (2012) · Ophthalmologica · doi:10.1159/000328979 · Cited by 436
CHOLONGITAS, E., PAPATHEODORIDIS, G. V., VANGELI, M., TERRENI, N., PATCH, D., & BURROUGHS, A. K. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02691.x · Cited by 420
Prognostic value of muscle atrophy in cirrhosis using psoas muscle thickness on computed tomography
Durand, F., Buyse, S., Francoz, C., Laouénan, C., Bruno, O., Belghiti, J., Moreau, R., Vilgrain, V., & Valla, D. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.02.026 · Cited by 384
Prognostic Importance of the Cause of Renal Failure in Patients With Cirrhosis
Martín–Llahí, M., Guevara, M., Torre, A., Fagundes, C., Restuccia, T., Gilabert, R., Solá, E., Pereira, G., Marinelli, M., Pavesi, M., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.07.043 · Cited by 372
Portal Hypertension and Its Complications
Sanyal, A. J., Bosch, J., Blei, A., & Arroyo, V. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.007 · Cited by 358
Self-citationHyponatremia in cirrhosis: Pathogenesis, clinical significance, and management
Ginès, P., & Guevara, M. (2008) · Hepatology · doi:10.1002/hep.22418 · Cited by 323
Halldorson, J. B., Bakthavatsalam, R., Fix, O., Reyes, J. D., & Perkins, J. D. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02491.x · Cited by 318
Cholongitas, E., Marelli, L., Shusang, V., Senzolo, M., Rolles, K., Patch, D., & Burroughs, A. K. (2006) · Liver Transplantation · doi:10.1002/lt.20824 · Cited by 302
Kalafateli, M., Mantzoukis, K., Choi Yau, Y., Mohammad, A. O., Arora, S., Rodrigues, S., de Vos, M., Papadimitriou, K., Thorburn, D., O'Beirne, J., et al. (2017) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12095 · Cited by 291
Heuman, D. M., Mihas, A. A., Habib, A., Gilles, H. S., Stravitz, R. T., Sanyal, A. J., & Fisher, R. A. (2007) · Liver Transplantation · doi:10.1002/lt.20906 · Cited by 290
Self-citationHepatic Encephalopathy As a Predictor of Survival in Patients with End-Stage Liver Disease
Stewart, C. A., Malinchoc, M., Kim, R. W., & Kamath, P. S. (2007) · Liver Transplantation · doi:10.1002/lt.21129 · Cited by 277
Terra, C., Guevara, M., Torre, A., Gilabert, R., Fernández, J., Martín-Llahí, M., Baccaro, M. E., Navasa, M., Bru, C., Arroyo, V., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.09.024 · Cited by 256
The MELD score in patients awaiting liver transplant: Strengths and weaknesses
Bernardi, M., Gitto, S., & Biselli, M. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.11.008 · Cited by 174
Metadata
- Authors
- Heuman, D. M., Abou-Assi, S. G., Habib, A., Williams, L. M., Stravitz, T. R., Sanyal, A. J., Fisher, R. A., & Mihas, A. A.
- Venue
- Hepatology
- Published
- 2004-10
- Volume
- 40
- Issue
- 4
- Pages
- 802-810
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W1979393114
- Cited by
- 546
- References
- 26
- FWCI
- 17.92
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.